Recent Drug Approvals Transforming Oncology Care

Recent Drug Approvals Transforming Oncology Care

The FDA and the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) have approved or recommended a wave of new drugs that are set to transform cancer treatment. These approvals span across various oncological areas, including...
Recent Drug Approvals Transforming Oncology Care

FDA approves tarlatamab for ES-SCLC

On May 16, 2024, the Food and Drug Administration (FDA) gave accelerated approval to Imdelltra (tarlatamab-dlle), developed by Amgen, Inc., for treating extensive stage small cell lung cancer (ES-SCLC) that has progressed despite platinum-based chemotherapy. In a...